Know Labs (NYSEAMERICAN:KNW) Trading 3.8% Higher – Should You Buy?

Know Labs, Inc. (NYSEAMERICAN:KNW) shot up 3.8% on Thursday . The stock traded as high as $2.17 and last traded at $2.1390. 612,050 shares changed hands during mid-day trading, an increase of 60% from the average session volume of 381,756 shares. The stock had previously closed at $2.06.

Know Labs Trading Up 3.8%

The stock’s 50-day moving average is $2.14 and its 200-day moving average is $2.24. The stock has a market cap of $16.04 million, a price-to-earnings ratio of -0.33 and a beta of 1.83.

Hedge Funds Weigh In On Know Labs

Hedge funds have recently made changes to their positions in the business. United Capital Management of KS Inc. purchased a new stake in Know Labs during the 2nd quarter worth approximately $49,000. Bard Financial Services Inc. acquired a new stake in shares of Know Labs during the third quarter worth approximately $80,000. Corient Private Wealth LLC acquired a new stake in Know Labs in the second quarter valued at $99,000. Finally, Cerity Partners LLC bought a new position in Know Labs during the 2nd quarter valued at $158,000. Hedge funds and other institutional investors own 23.96% of the company’s stock.

Know Labs Company Profile

Know Labs, Inc (NYSE American: KNW) is a life sciences company developing non‐invasive sensing solutions based on its proprietary Bio‐RFID platform. The technology employs low‐power radio‐frequency spectroscopy to scan the skin, enabling the detection of biochemical markers such as blood glucose, hydration levels and alcohol concentration without the need for blood draws or fingersticks. By applying sophisticated signal‐processing algorithms to reflected electromagnetic waves, the company aims to deliver real‐time, continuous monitoring devices that could transform standard practices in healthcare and wellness.

The company is focused on advancing its flagship prototype devices through clinical validation studies and regulatory pathways.